GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acotec Scientific Holdings Ltd (STU:7W3) » Definitions » Revenue per Share

Acotec Scientific Holdings (STU:7W3) Revenue per Share : €0.23 (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acotec Scientific Holdings Revenue per Share?

Acotec Scientific Holdings's revenue per share for the six months ended in Dec. 2024 was €0.11. Acotec Scientific Holdings's revenue per share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.23.

Warning Sign:

Acotec Scientific Holdings Ltd revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue Per Share Growth Rate of Acotec Scientific Holdings was 10.10% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 8.10% per year. During the past 5 years, the average Revenue Per Share Growth Rate was 32.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Acotec Scientific Holdings's Revenue per Share or its related term are showing as below:

STU:7W3' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 8.1   Med: 32.9   Max: 49.2
Current: 8.1

During the past 6 years, Acotec Scientific Holdings's highest 3-Year average Revenue Per Share Growth Rate was 49.20% per year. The lowest was 8.10% per year. And the median was 32.90% per year.

STU:7W3's 3-Year Revenue Growth Rate is ranked better than
60.75% of 749 companies
in the Medical Devices & Instruments industry
Industry Median: 4.2 vs STU:7W3: 8.10

Acotec Scientific Holdings Revenue per Share Historical Data

The historical data trend for Acotec Scientific Holdings's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acotec Scientific Holdings Revenue per Share Chart

Acotec Scientific Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Revenue per Share
Get a 7-Day Free Trial 0.08 0.17 0.18 0.20 0.23

Acotec Scientific Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.10 0.10 0.10 0.12 0.11

Competitive Comparison of Acotec Scientific Holdings's Revenue per Share

For the Medical Devices subindustry, Acotec Scientific Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acotec Scientific Holdings's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where Acotec Scientific Holdings's PS Ratio falls into.


;
;

Acotec Scientific Holdings Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Acotec Scientific Holdings's Revenue Per Share for the fiscal year that ended in Dec. 2024 is calculated as

Revenue Per Share (A: Dec. 2024 )=Revenue (A: Dec. 2024 )/Shares Outstanding (Diluted Average) (A: Dec. 2024 )
=70.043/301.078
=0.23

Acotec Scientific Holdings's Revenue Per Share for the quarter that ended in Dec. 2024 is calculated as

Revenue Per Share (Q: Dec. 2024 )=Revenue (Q: Dec. 2024 )/Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
=31.697/300.899
=0.11

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acotec Scientific Holdings  (STU:7W3) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Acotec Scientific Holdings Revenue per Share Related Terms

Thank you for viewing the detailed overview of Acotec Scientific Holdings's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Acotec Scientific Holdings Business Description

Traded in Other Exchanges
Address
16 North Hongda Road, 4-5th Floor, Building No. 1, Beijing Economic-Technological Development Area, Beijing, CHN
Acotec Scientific Holdings Ltd is a medical device company. The company is focused on providing leave nothing behind treatment solutions for vascular diseases. It has developed a suite of interventional medical devices featuring world- leading technologies, notably in the fields of drug-coated balloons and thrombus aspiration catheters. The company's commercialized product is Semi-compliant PTCA Balloon (YAN) is a product designed for dilation in coronary artery or coronary artery bypass vessels stenosis to improve myocardial perfusion. Geographically, the company operates from Mainland China, Europe and Other countries and regions. Majority of revenue is generated from Mainland China.

Acotec Scientific Holdings Headlines

No Headlines